Oral glucocorticoids: Clinical Trials

4 trials of Oral glucocorticoids, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 2 unknown. 2 Phase 2, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 2
Phase 42Unknown 2

Follow Oral glucocorticoids: new trials by email Literature Review of Oral glucocorticoids trials Research Report on Oral glucocorticoids

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A 52-Week Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants With VEXAS Followed by Open-Label Extension (OLE) Period
Arumakimig, Placebo, Oral glucocorticoids - VEXAS Syndrome
Phase 2RecruitingNovartis Pharmaceuticals1202026-10-302026-10-13
A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)
JYP0061, Intravenous Glucocorticoids, Oral Glucocorticoids - Neuromyelitis Optica Spectrum Disorders
Phase 2RecruitingGuangzhou JOYO Pharma Co., Ltd352023-05-242024-11-20
CST1 Predictive Model of Oral Glucocorticoid Therapy Sensitivity for Chronic Rhinosinusitis With Polyps
Oral Glucocorticoids - Chronic Rhinosinusitis With Nasal Polyps, Glucocorticoids
Phase 4UnknownBeijing Tongren Hospital1502022-11-222023-03-10
CST1-Guided Oral Glucocorticoids Management for CRSwNP
Oral Glucocorticoids, Oral placebo - Chronic Rhinosinusitis With Nasal Polyps, Glucocorticoids
Phase 4UnknownBeijing Tongren Hospital902022-10-172022-10-28

Conditions studied

Arthralgia (1)  ·  Arthritis (1)  ·  Neuromyelitis Optica (1)  ·  VEXAS syndrome (1)

Sponsors

Beijing Tongren Hospital (2)  ·  Guangzhou JOYO Pharma Co., Ltd (1)  ·  Novartis Pharmaceuticals (1)

Countries

China (3)  ·  Japan (1)

Top investigators

Luo Zhang (2)

Results publications

PMID 42854989